Product NDC: | 24208-416 |
Proprietary Name: | Retisert |
Non Proprietary Name: | Fluocinolone Acetonide |
Active Ingredient(s): | .59 mg/1 & nbsp; Fluocinolone Acetonide |
Administration Route(s): | INTRAVITREAL |
Dosage Form(s): | IMPLANT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 24208-416 |
Labeler Name: | Bausch & Lomb Incorporated |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021737 |
Marketing Category: | NDA |
Start Marketing Date: | 20050408 |
Package NDC: | 24208-416-01 |
Package Description: | 1 POUCH in 1 CARTON (24208-416-01) > 1 IMPLANT in 1 POUCH |
NDC Code | 24208-416-01 |
Proprietary Name | Retisert |
Package Description | 1 POUCH in 1 CARTON (24208-416-01) > 1 IMPLANT in 1 POUCH |
Product NDC | 24208-416 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fluocinolone Acetonide |
Dosage Form Name | IMPLANT |
Route Name | INTRAVITREAL |
Start Marketing Date | 20050408 |
Marketing Category Name | NDA |
Labeler Name | Bausch & Lomb Incorporated |
Substance Name | FLUOCINOLONE ACETONIDE |
Strength Number | .59 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |